APO-AMITRIPTYLINE 10mg (2021-04-29)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
APO-AMITRIPTYLINE 10mg
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| PY1831 | - Recalling Firm
- Apotex Inc.
- 150 Signet Drive
- Toronto
- M9L 1T9
- Ontario
- CANADA
- Marketing Authorization Holder
- Apotex Inc.
- 150 Signet Drive
- Toronto
- M9L 1T9
- Ontario
- CANADA
| APO-AMITRIPTYLINE | DIN 02403137 | Tablet | AMITRIPTYLINE HYDROCHLORIDE 10mg |
Presence of higher than accepted levels of a nitrosamine impurity known as N-nitrosodimethylamine (NDMA) in the affected lot.
Retailers, Wholesalers, Healthcare Establishments